phrykt

Creative Medical Technology Holdings, Inc. (CELZ): who owns it and who trades it

As of Nov 16, 2026, no open-market insider purchases or sales of CELZ were reported in the last 12 months. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Insider trades

No CELZ insider reported an open-market purchase or sale in the last 12 months.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
–
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CELZ short interest

Low short interest. 1.0% of CELZ shares are sold short: about 1 share in 100. Over the last 12 reports the number of shares short went down 51%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 66,165 CELZ shares were sold short, 1.0% of the shares outstanding, down 19.4% from the report before. At the average daily volume of 110,768 shares, buying them all back would take about 1.0 trading days (days to cover).

Shares short, % of all shares

1.00%May 15Oct 3018.6%

Days to cover

1.0May 15Oct 303.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202666,1651.00%-19%110,7681.0
Oct 15, 202682,0521.24%-50%94,5631.0
Sep 30, 2026164,7822.50%+96%2.14M1.0
Sep 15, 202684,2561.28%-69%172,0851.0
Aug 31, 2026272,8124.14%-53%1.22M1.0
Aug 14, 2026584,6098.87%+823%38.49M1.0
Jul 31, 202663,3071.71%-17%168,5091.0
Jul 15, 202676,2632.06%-87%1.10M1.0
Jun 30, 2026602,28516.29%+289%18.97M1.0
Jun 15, 2026154,8174.19%+14%53,1122.9
May 29, 2026135,6253.67%+1%48,6432.8
May 15, 2026133,7333.62%-6%44,4213.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Creative Medical Technology Holdings company events

Creative Medical Technology Holdings filed 5 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Sep 25, 2026.

  1. Sep 25, 2026AgreementCreative Medical Technology Holdings, Inc. entered into a Stock Purchase Agreement with Creative Acquisition Corp., pursuant to which the Company purchased 4,000,000 shares of common stock of BioDefense, Inc. from CAC for an aggregate purchase price consisting of $200,000 in cash and 1,000,000… Filing
  2. Aug 31, 2026VoteReported shareholder vote results. Filing
  3. Jul 2, 2026LeadershipThe Compensation Committee of the Company’s Board of Directors approved the payment of a bonus to Timothy Warbington, the Company’s Chief Executive Officer, in the amount of $100,000. Filing
  4. Dec 31, 2025VoteReported shareholder vote results. Filing
  5. Dec 19, 2025VoteReported shareholder vote results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Creative Medical Technology Holdings financials

Famous investors that hold CELZ

1 of the 50 well-known investors we track reported holding CELZ in their latest 13F filing. The largest position is Ken Griffin's, worth $24.6K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202626,295$24.6K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CELZ in the last 120 days.

FiledHolderFormStake
Oct 1, 2026Timothy Warbington13D13.7%
Oct 1, 2026Timothy Warbington13D13.7%

Questions about Creative Medical Technology Holdings, Inc. (CELZ) stock

Are CELZ insiders buying or selling?

No CELZ insider reported an open-market purchase or sale on Form 4 in the last 12 months. Share awards, option exercises and gifts are not counted.

What is the short interest in CELZ?

As of Oct 30, 2026, 66,165 CELZ shares were sold short, 1.0% of the shares outstanding, down 19.4% from the report before. At the average daily volume of 110,768 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.

Which famous investors hold CELZ?

1 of the 50 well-known investors we track reported CELZ in their latest 13F filing, including Ken Griffin. The largest position is worth $24.6K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.